ResMed to pay down revolver via proceeds of 3.24%, 3.45% notes

By Wendy Van Sickle

Columbus, Ohio, July 15 – ResMed Inc. plans to pay down borrowings under its revolving credit facility with proceeds of $500 million of senior notes in tranches due in seven and 10 years, according to an 8-K filing with the Securities and Exchange Commission.

The company sold on July 10 a $250 million tranche of 3.24% series A senior notes due July 10, 2026 and a $250 million tranche of 3.45% series B senior notes due July 10, 2029.

ResMed is a San Diego-based provider of cloud-connected medical devices and out-of-hospital software-as-a-service business solutions.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.